Carlsbad, CA, United States of America

Jon Holmlund

This inventor holds 1 USPTO granted patent. Top assignees: Biossil Inc., Northwestern University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Holmlund. Retrieved from https://idiyas.com/inventor/jon-holmlund-jelmxgiw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jon Holmlund: Cancer-Therapy Inventor

Introduction

Jon Holmlund is an inventor associated with Carlsbad, California. His patent work concerns a potential approach to treating cancers that resist multiple therapies.

Latest Patents

The supplied information lists one patent for Holmlund: “Combination Cancer Therapy with Pentaaza Macrocyclic Ring Complex and Hormone Therapy Agent.” The patent describes treating cancer in a mammalian subject with multi-therapy resistance by administering a therapeutically effective amount of a pentaaza macrocyclic ring complex, optionally alongside another anticancer therapy. The record lists 1 patent.

Career Highlights

Holmlund’s listed affiliations include Biossil Inc. and Northwestern University. The available information does not specify his roles or the dates of these affiliations.

Collaborations

The supplied information names David R. Gius and Robert A. Beardsley as Holmlund’s coworkers. It does not detail their specific contributions to the patent.

Conclusion

Jon Holmlund’s listed patent focuses on a combination-based strategy for addressing cancers with resistance to multiple therapies, reflecting his documented connection to cancer-treatment innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…